Gene: RNPEP
Official Full Name: arginyl aminopeptidaseprovided by HGNC
Gene Summary: Predicted to enable metalloaminopeptidase activity. Predicted to be involved in proteolysis. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35600 | RNPEP Knockout cell line (HeLa) | Human | RNPEP | 1:3~1:6 | Negative | Online Inquiry |
KO35601 | RNPEP Knockout cell line (HCT 116) | Human | RNPEP | 1:2~1:4 | Negative | Online Inquiry |
KO35602 | RNPEP Knockout cell line (HEK293) | Human | RNPEP | 1:3~1:6 | Negative | Online Inquiry |
KO35603 | RNPEP Knockout cell line (A549) | Human | RNPEP | 1:3~1:4 | Negative | Online Inquiry |
RNPEP Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of the RNPEP gene, which encodes for the enzyme renal dipeptidase. This product involves the targeted disruption of the RNPEP gene through CRISPR-Cas9 technology, enabling researchers to create models that lack the functional protein. By employing precise gene-editing techniques, these cell lines are invaluable for investigating the biological roles of RNPEP in various physiological processes, including amino acid metabolism and the regulation of blood pressure.
The primary function of RNPEP Gene Knockout Cell Lines lies in their ability to support research that elucidates the metabolic pathways involving renal dipeptidase. The cells display altered metabolic profiles, allowing for unique insights into the implications of kidney function, hypertension, and cardiovascular health. Moreover, these knockout models are essential for pharmacological studies, toxicity assessments, and drug development processes aimed at targeting renal-related disorders.
The scientific importance of these cell lines extends into both research and clinical settings. Their applications range from fundamental studies in molecular biology to advanced translational research aimed at developing therapeutic strategies for renal diseases. The ability to create specific gene knockouts accelerates the discovery of gene functions and pathological mechanisms, which is critical for advancing personalized medicine.
In contrast to traditional knockout models, RNPEP Gene Knockout Cell Lines utilize cutting-edge CRISPR technology, offering higher specificity and efficiency in gene editing. This precision reduces off-target effects and enhances the reliability of experimental outcomes. Researchers benefit from a more streamlined and reproducible approach, leading to time and cost-effective study designs.
Moreover, these cell lines are backed by extensive validation and characterization, ensuring robust performance in a variety of experimental conditions. For researchers and clinicians who aim for quality and reliability in their studies, RNPEP Gene Knockout Cell Lines stand out as an essential tool.
Our company is committed to providing high-quality biological products that support innovative research and clinical advancements. Leveraging our expertise in genetic engineering and cell line development, we empower scientists to explore new horizons in biological research effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.